Louis Ignarro | Academic Influence

Louis Ignarro's AcademicInfluence.com Rankings

Louis Ignarro

Biology

#425

World Rank

#767

Historical Rank

#254

USA Rank

Physiology

#8

World Rank

#48

Historical Rank

#4

USA Rank

biology Degrees

Download Badge

Biology

Louis Ignarro's Degrees

Bachelors Pharmacy Columbia University

Why Is Louis Ignarro Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Louis José Ignarro is an American pharmacologist. For demonstrating the signaling properties of nitric oxide, he was co-recipient of the 1998 Nobel Prize in Physiology or Medicine with Robert F. Furchgott and Ferid Murad.

(See a Problem?)

Louis Ignarro's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. (1987) (4898)
Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. (1981) (1667)
Biosynthesis and metabolism of endothelium-derived nitric oxide. (1990) (1272)
Endothelium‐Derived Relaxing Factor From Pulmonary Artery and Vein Possesses Pharmacologic and Chemical Properties Identical to Those of Nitric Oxide Radical (1987) (1173)
Biological Actions and Properties of Endothelium-Derived Nitric Oxide Formed and Released From Artery and Vein (1989) (1015)
Nitric oxide : biology and pathobiology (2000) (915)
Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. (1990) (829)
Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine. (1993) (805)
Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. (1993) (801)
Nitric oxide as a signaling molecule in the vascular system: an overview. (1999) (776)
Endothelium‐derived nitric oxide: actions and properties (1989) (666)
Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. (2002) (641)
Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission (1992) (638)
Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. (1981) (609)
Relationship between cyclic guanosine 3':5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. (1981) (552)
Signal transduction mechanisms involving nitric oxide. (1991) (519)
Shear Stress‐Induced Release of Nitric Oxide From Endothelial Cells Grown on Beads (1991) (516)
Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. (1992) (500)
Nitric oxide. A novel signal transduction mechanism for transcellular communication. (1990) (499)
Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. (1979) (471)
Free radical biology and medicine: it's a gas, man! (2006) (470)
The Pharmacological and Physiological Role of Cyclic GMP in Vascular Smooth Muscle Relaxation (1985) (446)
Nitric oxide and atherosclerosis: an update. (2006) (436)
Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. (1986) (431)
Nutrition, physical activity, and cardiovascular disease: an update. (2007) (431)
Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. (2002) (421)
Phase II Study of Pomegranate Juice for Men with Rising Prostate-Specific Antigen following Surgery or Radiation for Prostate Cancer (2006) (418)
Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. (1992) (409)
Negative feedback regulation of endothelial cell function by nitric oxide. (1993) (393)
Nitric oxide and atherosclerosis. (2001) (385)
Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells (2006) (333)
Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite. (1981) (328)
Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation (2001) (325)
Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite: possible involvement of S-nitrosothiols. (1980) (323)
Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. (1992) (316)
Small molecule signaling agents: the integrated chemistry and biochemistry of nitrogen oxides, oxides of carbon, dioxygen, hydrogen sulfide, and their derived species. (2012) (305)
The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. (1985) (300)
Nitric oxide: a unique endogenous signaling molecule in vascular biology. (1999) (299)
The L-arginine paradox: Importance of the L-arginine/asymmetrical dimethylarginine ratio. (2007) (298)
Association between cyclic GMP accumulation and acetylcholine-elicited relaxation of bovine intrapulmonary artery. (1984) (280)
Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B. (1996) (274)
Nitric oxide as a potential pathological mechanism in demyelination: Its differential effects on primary glial cellsin vitro (1994) (262)
Activation of soluble guanylate cyclase by NO-hemoproteins involves NO-heme exchange. Comparison of heme-containing and heme-deficient enzyme forms. (1986) (260)
Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases (2009) (258)
Arginase activity in endothelial cells: inhibition by NG-hydroxy-L-arginine during high-output NO production. (1996) (256)
Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages. (1993) (253)
Constitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide formed from L-arginine. (1992) (252)
Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung. (1982) (248)
Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation. (1988) (248)
Platelets modulate gastric ulcer healing: Role of endostatin and vascular endothelial growth factor release (2001) (243)
Regulation of soluble guanylate cyclase activity by porphyrins and metalloporphyrins. (1984) (237)
Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. (1995) (234)
Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide. (1993) (233)
Formation of free nitric oxide from l-arginine by nitric oxide synthase: direct enhancement of generation by superoxide dismutase. (1994) (233)
L-arginine inhibits balloon catheter-induced intimal hyperplasia. (1993) (229)
Haem-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: a unique transduction mechanism for transcellular signaling. (1990) (228)
A spectrophotometric assay for nitrate using NADPH oxidation by Aspergillus nitrate reductase. (1993) (222)
The role of oxidative stress in adult critical care (2006) (220)
Effects of nitric oxide on cell proliferation: novel insights. (2013) (217)
Nitric oxide-releasing drugs. (2003) (201)
Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation. (1983) (197)
Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes (1995) (197)
Nitric Oxide: A Unique Endogenous Signaling Molecule in Vascular Biology (1999) (194)
Activation of purified soluble guanylate cyclase by protoporphyrin IX. (1982) (194)
Nitric oxide inhibits neuronal nitric oxide synthase by interacting with the heme prosthetic group. Role of tetrahydrobiopterin in modulating the inhibitory action of nitric oxide. (1994) (193)
Lipopolysaccharide-induced Expression of Interferon-β Mediates the Timing of Inducible Nitric-oxide Synthase Induction in RAW 264.7 Macrophages* (2001) (192)
Endothelial cellular senescence is inhibited by nitric oxide: Implications in atherosclerosis associated with menopause and diabetes (2006) (191)
Neuronal Nitric Oxide Synthase Self-inactivates by Forming a Ferrous-Nitrosyl Complex during Aerobic Catalysis (*) (1995) (188)
Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum. (1992) (185)
Vascular smooth muscle-derived relaxing factor (MDRF) and its close similarity to nitric oxide. (1990) (185)
Nitric oxide-cyclic GMP signal transduction system. (1996) (183)
Nitric oxide synthase from cerebellum catalyzes the formation of equimolar quantities of nitric oxide and citrulline from L-arginine. (1992) (179)
Hydrogen sulfide as a mediator of human corpus cavernosum smooth-muscle relaxation (2009) (171)
Possible involvement of S‐nitrosothiols in the activation of guanylate cyclase by nitroso compounds (1980) (171)
Endothelium-dependent modulation of cGMP levels and intrinsic smooth muscle tone in isolated bovine intrapulmonary artery and vein. (1987) (169)
Negative modulation of nitric oxide synthase by nitric oxide and nitroso compounds. (1995) (164)
Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension. (2004) (163)
Guanylate cyclase from bovine lung. A kinetic analysis of the regulation of the purified soluble enzyme by protoporphyrin IX, heme, and nitrosyl-heme. (1982) (163)
IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells. (2000) (162)
Pomegranate juice protects nitric oxide against oxidative destruction and enhances the biological actions of nitric oxide. (2006) (160)
Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation (2001) (155)
Beneficial effects of pomegranate juice on oxidation-sensitive genes and endothelial nitric oxide synthase activity at sites of perturbed shear stress. (2005) (152)
Appearance and concentrations of catecholamines and their biosynthesis in the embryonic and developing chick. (1968) (142)
Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. (2005) (140)
Nitric oxide : biochemistry, molecular biology, and therapeutic implications (1995) (140)
l-Citrulline and l-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits. (2005) (139)
Potential cardioprotective actions of no-releasing aspirin (2002) (135)
Mechanisms by which exercise training benefits patients with heart failure (2009) (135)
Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxation. (1989) (134)
Haem-dependent activation of cytosolic guanylate cyclase by nitric oxide: a widespread signal transduction mechanism. (1992) (132)
Effects of anti-inflammatory drugs on the stability of rat liver lysosomes in vitro. (1971) (131)
The influence of pomegranate fruit extract in comparison to regular pomegranate juice and seed oil on nitric oxide and arterial function in obese Zucker rats. (2007) (130)
Biological hydropersulfides and related polysulfides – a new concept and perspective in redox biology (2018) (130)
Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and VIP. (1987) (128)
Inducible Nitric-oxide Synthase and Nitric Oxide Production in Human Fetal Astrocytes and Microglia (1997) (127)
Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice. (2004) (123)
Nonsteroidal anti-inflammatory drugs inhibit expression of the inducible nitric oxide synthase gene. (1995) (123)
Cutting Edge: Antisense Knockdown of Inducible Nitric Oxide Synthase Inhibits Induction of Experimental Autoimmune Encephalomyelitis in SJL/J Mice (1998) (122)
Conversion of nitroxyl (HNO) to nitric oxide (NO) in biological systems: the role of physiological oxidants and relevance to the biological activity of HNO. (1993) (121)
Nitric oxide and cGMP: mediators of pelvic nerve-stimulated erection in dogs. (1993) (121)
HORMONAL CONTROL OF LYSOSOMAL ENZYME RELEASE FROM HUMAN NEUTROPHILS (1974) (119)
Nitric Oxide Inhibits Ornithine Decarboxylase viaS-Nitrosylation of Cysteine 360 in the Active Site of the Enzyme* (2001) (118)
Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart. (2000) (114)
Beneficial effects of antioxidants and l-arginine on oxidation-sensitive gene expression and endothelial NO synthase activity at sites of disturbed shear stress (2003) (113)
Regulation of purified soluble guanylate cyclase by porphyrins and metalloporphyrins: a unifying concept. (1984) (112)
Microcirculation and oxidative stress (2007) (112)
Biosynthesis of nitric oxide and citrulline from L-arginine by constitutive nitric oxide synthase present in rabbit corpus cavernosum. (1992) (112)
Evidence-based use of pulsed electromagnetic field therapy in clinical plastic surgery. (2009) (108)
Bioregulation of lysosomal enzyme secretion from human neutrophils: roles of guanosine 3':5'-monophosphate and calcium in stimulus-secretion coupling. (1975) (107)
Effects of a pomegranate fruit extract rich in punicalagin on oxidation-sensitive genes and eNOS activity at sites of perturbed shear stress and atherogenesis. (2007) (106)
Heme-dependent activation of guanylate cyclase by nitric oxide: a novel signal transduction mechanism. (1991) (105)
Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat. (1999) (104)
Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis. (2003) (104)
Endothelium-derived nitric oxide relaxes nonvascular smooth muscle. (1989) (103)
CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy (2010) (101)
Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle. (1988) (100)
Estrogen-related receptor α1 up-regulates endothelial nitric oxide synthase expression (2003) (98)
Nitric oxide (NO)-releasing statin derivatives, a class of drugs showing enhanced antiproliferative and antiinflammatory properties. (2004) (98)
Rapid nitric oxide-mediated S-nitrosylation of estrogen receptor: regulation of estrogen-dependent gene transcription. (2005) (98)
Condensed expirate nitrite as a home marker for acute asthma (1995) (97)
Reversal to cisplatin sensitivity in recurrent human ovarian cancer cells by NCX-4016, a nitro derivative of aspirin. (2006) (96)
After 130 years, the molecular mechanism of action of nitroglycerin is revealed (2002) (96)
Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis (2004) (96)
Guanylate cyclase activation of nitroprusside and nitrosoguanidine is related to formation of S-nitrosothiol intermediates. (1980) (95)
Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis (2005) (94)
An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity (2001) (93)
RELEASE OF CARTILAGE MUCOPOLYSACCHARIDE-DEGRADING NEUTRAL PROTEASE FROM HUMAN LEUKOCYTES (1973) (93)
Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release. (1991) (90)
Purification and properties of heme-deficient hepatic soluble guanylate cyclase: effects of heme and other factors on enzyme activation by NO, NO-heme, and protoporphyrin IX. (1982) (90)
Endothelium-Derived Nitric Oxide: Pharmacology and Relationship to the Actions of Organic Nitrate Esters (1989) (90)
Hormonal control of lysosomal enzyme release from human neutrophils: elevation of cyclic nucleotide levels by autonomic neurohormones. (1974) (89)
Melatonin synergistically increases resveratrol‐induced heme oxygenase‐1 expression through the inhibition of ubiquitin‐dependent proteasome pathway: a possible role in neuroprotection (2010) (89)
Nitric oxide-mediated neuronal injury in multiple sclerosis. (1992) (88)
Pulmonary vasoconstriction due to impaired nitric oxide production after cardiopulmonary bypass. (1996) (88)
Inducible nitric oxide synthase and nitric oxide production by oligodendrocytes (1997) (86)
In Vivo Aspects of Nitric Oxide (NO) Chemistry: Does Peroxynitrite (-OONO) Play a Major Role in Cytotoxicity? (1997) (86)
Influence of Zaprinast on vascular tone and vasodilator responses in the cat pulmonary vascular bed. (1993) (84)
Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice (2001) (84)
Physiology and pathophysiology of nitric oxide. (1996) (83)
Pharmacology of endothelium-derived nitric oxide and nitrovasodilators. (1991) (82)
Experimental evidences of nitric oxide‐dependent vasodilatory activity of nebivolol, a third‐generation β‐blocker (2004) (82)
Characterization and actions of human umbilical endothelium derived relaxing factor (1991) (80)
Gender Differences in Atherosclerosis: Possible Role of Nitric Oxide (1995) (80)
Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis (2002) (79)
Dissimilarities between methylene blue and cyanide on relaxation and cyclic GMP formation in endothelium-intact intrapulmonary artery caused by nitrogen oxide-containing vasodilators and acetylcholine. (1986) (79)
Nebivolol: a selective beta(1)-adrenergic receptor antagonist that relaxes vascular smooth muscle by nitric oxide- and cyclic GMP-dependent mechanisms. (2002) (79)
Circulating levels of nitric oxide in fertile women in relation to the menstrual cycle. (1996) (78)
Role of oxidative stress in experimental sepsis and multisystem organ dysfunction (2006) (78)
Deletion of Yin Yang 1 protein in osteosarcoma cells on cell invasion and CXCR4/angiogenesis and metastasis. (2008) (77)
N G-hydroxy-l-arginine and nitric oxide inhibit Caco-2 tumor cell proliferation by distinct mechanisms. (1998) (77)
Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol. (2008) (77)
Brain protection using autologous bone marrow cell, metalloproteinase inhibitors, and metabolic treatment in cerebral ischemia (2007) (76)
Basic Polyamino Acids Rich in Arginine, Lysine, or Ornithine Cause Both Enhancement of and Refractoriness to Formation of Endothelium‐Derived Nitric Oxide in Pulmonary Artery and Vein (1989) (74)
Coronary arterial relaxation and guanylate cyclase activation by cigarette smoke, N'-nitrosonornicotine and nitric oxide. (1980) (73)
Beneficial effects of concurrent autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the mouse hindlimb. (2005) (72)
Enzyme Release from Polymorphonuclear Leukocyte Lysosomes: Regulation by Autonomic Drugs and Cyclic Nucleotides (1973) (72)
Endothelial progenitor cells as therapeutic agents in the microcirculation: an update. (2011) (71)
Serine and cysteine proteinase inhibitors prevent nitric oxide production by activated macrophages by interfering with transcription of the inducible NO synthase gene. (1995) (71)
NG-amino-L-arginine: a new potent antagonist of L-arginine-mediated endothelium-dependent relaxation. (1990) (71)
Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice. (1998) (71)
Antagonistic modulatory roles of magnesium and calcium on release of endothelium-derived relaxing factor and smooth muscle tone. (1990) (70)
NG-methyl-L-arginine causes endothelium-dependent contraction and inhibition of cyclic GMP formation in artery and vein. (1990) (70)
Nitric Oxide-mediated Vasorelaxation (1993) (70)
The link between erectile and cardiovascular health: the canary in the coal mine. (2011) (69)
D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet Published, JLR Papers in Press, July 12, 2006. (2006) (69)
Physiological release of nitric oxide is dependent on the level of vascular tone. (1990) (69)
Role of p42/p44 mitogen-activated-protein kinase and p21waf1/cip1 in the regulation of vascular smooth muscle cell proliferation by nitric oxide (2001) (69)
Nitric oxide inhibits ornithine decarboxylase by S-nitrosylation. (1999) (68)
L-arginine causes whereas L-argininosuccinic acid inhibits endothelium-dependent vascular smooth muscle relaxation. (1989) (68)
Pomegranate juice reduces oxidized low-density lipoprotein downregulation of endothelial nitric oxide synthase in human coronary endothelial cells. (2006) (67)
Relaxation of bovine coronary arterial smooth muscle by cyclic GMP, cyclic AMP and analogs. (1980) (67)
Dose-Dependent Modulatory Effects of Insulin on Glucose-Induced Endothelial Senescence In Vitro and In Vivo: A Relationship between Telomeres and Nitric Oxide (2011) (67)
NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice (2002) (67)
Evidence that regulation of hepatic guanylate cyclase activity involves interactions between catalytic site -SH groups and both substrate and activator. (1981) (67)
Norepinephrine and epinephrine in the embryo and embryonic heart of the chick: uptake and subcellular distribution. (1968) (65)
Loss of endothelium-dependent vasodilatation and nitric oxide release after myocardial protection with University of Wisconsin solution. (1994) (65)
Gene transfer of endothelial NO synthase, but not eNOS plus inducible NOS, regressed atherosclerosis in rabbits. (2004) (64)
Activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside, and nitrosoguanidine--inhibition by calcium, lanthanum, and other cations, enhancement by thiols. (1980) (64)
Involvement of β3-adrenergic receptor activation via cyclic GMP- but not NO-dependent mechanisms in human corpus cavernosum function (2003) (62)
MEDIATION OF IMMUNOLOGIC DISCHARGE OF LYSOSOMAL ENZYMES FROM HUMAN NEUTROPHILS BY GUANOSINE 3',5'-MONOPHOSPHATE (1974) (61)
Acute effects of transdermal estradiol administration on plasma levels of nitric oxide in postmenopausal women. (1997) (60)
NG-hydroxy-L-arginine and nitric oxide inhibit Caco-2 tumor cell proliferation by distinct mechanisms. (1998) (60)
Effects of ACE inhibition on circulating endothelial progenitor cells, vascular damage, and oxidative stress in hypertensive patients (2011) (60)
Calmangafodipir [Ca4Mn(DPDP)5], mangafodipir (MnDPDP) and MnPLED with special reference to their SOD mimetic and therapeutic properties. (2015) (59)
Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP. (1984) (58)
Lysosome membrane stabilization in vivo: effects of steroidal and nonsteroidal anti-inflammatory drugs on the integrity of rat liver lysosomes. (1972) (58)
Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts. (1994) (58)
Physical training and metabolic supplementation reduce spontaneous atherosclerotic plaque rupture and prolong survival in hypercholesterolemic mice (2006) (57)
Endothelial cellular senescence is inhibited by liver X receptor activation with an additional mechanism for its atheroprotection in diabetes (2014) (57)
NO is more important than PGI2 in maintaining low vascular tone in feto-placental vessels. (1993) (57)
Effects of estrogen replacement therapy on plasma levels of nitric oxide in postmenopausal women. (1999) (56)
NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols (2008) (56)
Estrogen-related receptor alpha 1 up-regulates endothelial nitric oxide synthase expression. (2003) (55)
Differences in responsiveness of intrapulmonary artery and vein to arachidonic acid: mechanism of arterial relaxation involves cyclic guanosine 3':5'-monophosphate and cyclic adenosine 3':5'-monophosphate. (1985) (54)
Lifestyle and metabolic approaches to maximizing erectile and vascular health (2012) (54)
Dissimilar effects of anti-inflammatory drugs on stability of lysosomes from peritoneal and circulating leukocytes and liver. (1971) (53)
Wei Lun Visiting Professorial Lecture: Nitric Oxide in the Regulation of Vascular Function: An Historical Overview (2001) (53)
Adipose tissue-derived stem cell-seeded small intestinal submucosa for tunica albuginea grafting and reconstruction (2012) (53)
Breakdown of noncollagenous chondromucoprotein matrix by leukocyte lysosome granule lysates from guinea pig, rabbit, and human. (1973) (52)
Role of nitric oxide in the relationship of pancreatic blood flow and exocrine secretion in cats. (1995) (51)
Regulation of inducible nitric oxide synthase expression in advanced glycation end product-stimulated raw 264.7 cells: the role of heme oxygenase-1 and endogenous nitric oxide. (2004) (50)
Pulmonary vasodilator responses to nitroprusside and nitroglycerin in the dog. (1981) (50)
Catechol-O-methyl transferase and monoamine oxidase activities in the heart and liver of the embryonic and developing chick. (1968) (50)
Enzyme release from guinea-pig polymorphonuclear leucocyte lysosomes inhibited in vitro by anti-inflammatory drugs. (1972) (50)
Nitric Oxide: A Unique Endogenous Signaling Molecule in Vascular Biology (Nobel Lecture) (1999) (50)
High glucose downregulates the number of caveolae in monocytes through oxidative stress from NADPH oxidase: implications for atherosclerosis. (2007) (50)
Estrogen Receptor-Mediated Vascular Responsiveness to Nebivolol: A Novel Endothelium-Related Mechanism of Therapeutic Vasorelaxation (2004) (50)
Endothelial stunning and myocyte recovery after reperfusion of jeopardized muscle: a role of L-arginine blood cardioplegia. (1997) (49)
Cytidine 3',5'-monophosphate (cyclic CMP) formation in mammalian tissues. (1977) (48)
Chapter 1 – Introduction and Overview (2000) (48)
Nitric oxide reduces early growth response-1 gene expression in rat lung macrophages treated with interferon-gamma and lipopolysaccharide. (1994) (47)
Deep hypothermic circulatory arrest and global reperfusion injury: avoidance by making a pump prime reperfusate--a new concept. (2003) (47)
EDRF generation and release from perfused bovine pulmonary artery and vein. (1988) (46)
NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and mdulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts (2008) (46)
L-arginine-dependent vascular smooth muscle relaxation and cGMP formation. (1990) (45)
Effects of prostaglandins on release of enzymes from lysosomes of pancreas, spleen and kidney cortex (1973) (44)
Changes in liver lysosome fragility, erythrocyte membrane stability, and local and systemic lysosomal enzyme levels in adjuvant-induced polyarthritis. (1972) (44)
Glycoxidized low-density lipoprotein downregulates endothelial nitricoxide synthase in human coronary cells. (2002) (44)
Atriopeptin II relaxes and elevates cGMP in bovine pulmonary artery but not vein. (1986) (44)
Regulation of cytosolic guanylyl cyclase by porphyrins and metalloporphyrins. (1994) (44)
Release of enzymes from a rat liver lysosome fraction: inhibition by catecholamines and cyclic3', 5'-adenosine monophosphate, stimulation by cholinergic agents and cyclic 3', 5'-guanosine monophosphate. (1973) (43)
Therapeutic dose of nebivolol, a nitric oxide-releasing beta-blocker, reduces atherosclerosis in cholesterol-fed rabbits. (2008) (43)
Bidirectional Regulation of Lysosomal Enzyme Secretion and Phagocytosis in Human Neutrophils by Guanosine 3′,5′-Monophosphate and Adenosine 3′,5′-Monophosphate 1 (1976) (43)
Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension. (2008) (42)
Oxidation of LDL to a biologically active form by derivatives of nitric oxide and nitrite in the absence of superoxide. Dependence on pH and oxygen. (1994) (42)
Guanylate cyclase from bovine lung. Evidence that enzyme activation by phenylhydrazine is mediated by iron-phenyl hemoprotein complexes. (1984) (41)
NITRIC OXIDE MEDIATED HYPOXIC INDUCED CORONARY VASODILATION (1992) (41)
Therapeutic Effects of Autologous Bone Marrow Cells and Metabolic Intervention in the Ischemic Hindlimb of Spontaneously Hypertensive Rats Involve Reduced Cell Senescence and CXCR4/Akt/eNOS Pathways (2007) (41)
Nitric Oxide Improves Cisplatin Cytotoxicity in Head and Neck Squamous Cell Carcinoma (2001) (41)
Cytidine 3',5'-monophosphate (cyclic CMP) formation by homogenates of mouse liver. (1978) (40)
Nebivolol inhibits vascular smooth muscle cell proliferation by mechanisms involving nitric oxide but not cyclic GMP. (2002) (40)
Gender differences of inducible nitric oxide production in SJL/J mice with experimental autoimmune encephalomyelitis (1997) (40)
Electrical field stimulation causes endothelium-dependent and nitric oxide-mediated relaxation of pulmonary artery. (1992) (40)
Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease (2008) (39)
Bone marrow cell-mediated cardiovascular repair: potential of combined therapies. (2007) (39)
A new HMG-CoA reductase inhibitor, pitavastatin remarkably retards the progression of high cholesterol induced atherosclerosis in rabbits. (2004) (38)
Erectile hydraulics: maximizing inflow while minimizing outflow. (2014) (38)
Neutral protease release from human leukocytes regulated by neurohormones and cyclic nucleotides. (1973) (38)
Nitric oxide: inhibitory effects on endothelial cell calcium signaling, prostaglandin I2 production and nitric oxide synthase expression. (2004) (37)
Nitric oxide is not just blowing in the wind (2018) (36)
A multifaceted approach to maximize erectile function and vascular health. (2010) (36)
Gastrointestinal motility during pregnancy: role of nitrergic component of NANC nerves. (2000) (35)
Concomitant production of nitric oxide and superoxide in human macrophages. (2003) (35)
Therapeutic targeting of the stem cell niche in experimental hindlimb ischemia (2008) (35)
Stimulation of phagocytic release of neutral protease from human neutrophils by cholinergic amines and cyclic 3',5'-guanosine monophosphate. (1974) (34)
17β-Estradiol inhibits NADPH oxidase activity through the regulation of p47phox mRNA and protein expression in THP-1 cells (2003) (34)
Nonphagocytic release of neutral protease and beta-glucuronidase from human neutrophils. Regulation by autonomic neurohormones and cyclic nucleotides. (1974) (33)
3 – Nitric Oxide as a Communication Signal in Vascular and Neuronal Cells (1996) (32)
Nitric oxide regulates endothelium-dependent vasodilator responses in rabbit hindquarters vascular bed in vivo. (1996) (32)
Sensing endoplasmic reticulum stress by protein kinase RNA‐like endoplasmic reticulum kinase promotes adaptive mitochondrial DNA biogenesis and cell survival via heme oxygenase‐1/carbon monoxide activity (2012) (32)
Hepatic cyclic GMP formation is regulated by similar factors that modulate activation of purified hepatic soluble guanylate cyclase. (1987) (31)
Neuroprotective effects of valproic acid against hemin toxicity: Possible involvement of the down-regulation of heme oxygenase-1 by regulating ubiquitin–proteasomal pathway (2013) (31)
Neurotransmitter identity doubt (1990) (31)
Release of neutral protease and beta-glucuronidase from human neutrophils in the presence of cartilage treated with various immunologic reactants. (1974) (31)
Studies of hypoxemic/reoxygenation injury: without aortic clamping. V. Role of the L-arginine-nitric oxide pathway: the nitric oxide paradox. (1995) (31)
Nuclear Fusion‐Independent Smooth Muscle Differentiation of Human Adipose‐Derived Stem Cells Induced by a Smooth Muscle Environment (2012) (30)
Low-dose l-arginine administration increases microperfusion of hindlimb muscle without affecting blood pressure in rats (2007) (30)
Oppositional effects of acetylcholine and isoproterenol on isometric tension and cyclic nucleotide concentrations in rabbit atria. (1975) (29)
Biphasic regulation of tissue plasminogen activator activity in ischemic rat brain and in cultured neural cells: Essential role of astrocyte-derived plasminogen activator inhibitor-1 (2011) (29)
Selective alterations in responsiveness of guanylate cyclase to activation by nitroso compounds during enzyme purification. (1981) (29)
Effects of short-term transdermal estradiol administration on plasma levels of nitric oxide in postmenopausal women. (1998) (29)
Acetylcholine vasodilation of resistance vessels in vivo may not entirely depend on newly synthesized nitric oxide. (1991) (29)
The protective effect of tetrahydrobiopterin on the nitric oxide-mediated inhibition of purified nitric oxide synthase. (1995) (28)
Autologous Bone Marrow Cell Therapy and Metabolic Intervention in Ischemia-Induced Angiogenesis in the Diabetic Mouse Hindlimb (2006) (28)
Different plasma levels of nitric oxide in arterial and venous blood. (1999) (27)
Heme-dependent activation of soluble guanylate cyclase by nitric oxide: regulation of enzyme activity by porphyrins and metalloporphyrins. (1989) (27)
Evidence for the presence of an unusual nitric oxide- and citrulline-producing enzyme in rat kidney. (1997) (27)
Hormonal Control of Neutrophil Lysosomal Enzyme Release: Effect of Epinephrine on Adenosine 3',5'-Monophosphate (1974) (27)
The presence of antagonistically acting alpha and beta adrenergic receptors in the mouse spleen. (1968) (27)
Acute arterial thrombosis causes endothelial dysfunction: a new paradigm for thrombolytic therapy. (2001) (27)
Detrimental effects of Bartonella henselae are counteracted by l-arginine and nitric oxide in human endothelial progenitor cells (2008) (27)
Up-Regulation of Endothelial Nitric Oxide Synthase through β2-Adrenergic Receptor—The Role of a β-Blocker with NO-Releasing Action (2001) (27)
Methemoglobin blockade of coronary arterial soluble guanylate cyclase activation by nitroso compounds and its reversal with dithiothreitol (1979) (26)
Physiological significance of endogenous nitric oxide. (1991) (26)
Chapter 26 Neurotransmitters and cytokines in CNS pathology (1994) (26)
Regulation of lysosomal enzyme secretion: Role in inflammation (1974) (25)
Preservation of endothelium-dependent vasodilation with low-potassium University of Wisconsin solution. (1996) (25)
Polymorphisms in endothelial nitric oxide synthase and carotid artery atherosclerosis (2006) (25)
Umbilical arterial S-nitrosothiols in stressed newborns: role in perinatal circulatory transition. (1998) (25)
Glucocorticosteroid inhibition of nonphagocytic discharge of lysosomal enzymes from human neutrophils. (1977) (25)
A salen-manganese catalytic free radical scavenger inhibits type 1 diabetes and islet allograft rejection. (2004) (25)
Therapeutic approaches in vascular repair induced by adult bone marrow cells and circulating progenitor endothelial cells. (2007) (25)
Directed in vivo angiogenesis assay and the study of systemic neoangiogenesis in cancer (2011) (25)
17beta-estradiol inhibits NADPH oxidase activity through the regulation of p47phox mRNA and protein expression in THP-1 cells. (2003) (25)
IL-4 and IL-13 upregulate ornithine decarboxylase expression by PI3K and MAP kinase pathways in vascular smooth muscle cells. (2008) (25)
Effects of methylene blue on hypoxic cerebral vasodilatation in the rabbit. (1990) (24)
Nuclear Factor-κB and Mitogen-activated Protein Kinases Mediate Nitric Oxide-enhanced Transcriptional Expression of Interferon-β* (2003) (24)
Activation of purified soluble guanylate cyclase by arachidonic acid requires absence of enzyme-bound heme. (1987) (24)
Effects of tibolone on plasma levels of nitric oxide in postmenopausal women. (2002) (23)
Combined effect of testosterone and apocynin on nitric oxide and superoxide production in PMA-differentiated THP-1 cells. (2004) (22)
Levels of nitric oxide metabolites do not increase during penile erection. (1993) (22)
The requriement of sympathetic innervation for the active transport of norepinephrine by the heart. (1968) (22)
Nitric oxide and prostacyclin inhibit fetal platelet aggregation: a response similar to that observed in adults. (1992) (22)
The unique role of nitric oxide as a signaling molecule in the cardiovascular system. (2000) (21)
Vasodilator actions of several N-nitroso compounds. (1982) (21)
IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK / STAT 6 pathways in vascular smooth muscle cells (2000) (21)
Inhaled NO and COVID‐19 (2020) (21)
The cloned neurotensin receptor mediates cyclic GMP formation when coexpressed with nitric oxide synthase cDNA. (1994) (21)
Inhibition of lysosomal enzyme release by catecholamines: possible mediation by cyclic 3',5'-adenosine monophosphate. (1971) (21)
Cell density-enhanced expression of inducible nitric oxide synthase in murine macrophages mediated by interferon-beta. (2003) (20)
Production and excretion of nitrate by human newborn infants: neonates are not little adults. (2000) (20)
Nitric oxide (NO) is a new clinical biomarker of survival in the elderly patients and its efficacy might be nearly equal to albumin. (2007) (19)
Sp1 transcription factor expression is regulated by estrogen-related receptor alpha1. (2005) (19)
Inhaled Nitric Oxide and COVID-19. (2020) (19)
Nitroaspirin (NCX-4016), an NO donor, is antiangiogenic through induction of loss of redox-dependent viability and cytoskeletal reorganization in endothelial cells. (2007) (18)
Increased nitric oxide concentrations in posterior hypothalamus and central sympathetic function on nitrate tolerance following subcutaneous nitroglycerin. (1999) (18)
Nitric oxide donors induce extrusion of cyclic GMP from isolated human blood platelets by a mechanism which may be modulated by prostaglandins. (1995) (18)
Biochemical and immunohistochemical characterization of nitric oxide synthase in the rat retina. (1996) (18)
Therapeutic angiogenesis in diabetic apolipoprotein E-deficient mice using bone marrow cells, functional hemangioblasts and metabolic intervention. (2010) (18)
Induction of arginase II in human Caco-2 tumor cells by cyclic AMP. (2000) (17)
Preservation of structural integrity of liver lysosomes and membrane-stabilizing action of anti-inflammatory drugs, catecholamines and cyclic adenosine monophosphate in isotonic salt media. (1973) (17)
Arachidonic acid activation of guinea pig lung guanylate cyclase by two independent mechanisms. (1979) (17)
Reduction of reoxygenation injury and nitric oxide production in the cyanotic immature heart by controlling pO2. (1995) (17)
Myocyte and endothelial effects of preconditioning the jeopardized heart by inhibiting Na/H exchange. (2002) (16)
Activation of hepatic guanylate cyclase by nitrosyl-heme complexes. Comparison of unpurified and partially purified enzyme. (1981) (16)
Nitric Oxide: A Unique Endogenous Signaling Molecule in Vascular Biology (Nobel Lecture). (1999) (16)
Inhibitors of nitric oxide promote microvascular thrombosis. (2003) (15)
Immunosuppressive effects of interleukin-12 coexpression in melanoma antigen gene–modified dendritic cell vaccines (2002) (15)
Nutrition and cardiovascular disease: putting a pathogenic framework into focus. (2007) (15)
Nitric-Oxide-Induced Reoxygenation Injury in the Cyanotic Immature Heart Is Prevented by Controlling Oxygen Content During Initial Reoxygenation (1997) (15)
Therapeutic effects of concurrent autologous bone marrow cell infusion and metabolic intervention in ischemia-induced angiogenesis in the hypercholesterolemic mouse hindlimb. (2007) (15)
Endothelial dysfunction after arterial thrombosis is ameliorated by L-arginine in combination with thrombolysis. (2003) (14)
Preface to this special journal issue on nitric oxide chemistry and biology (2009) (14)
Inhibition of lysosomal enzyme release by adenosine 5' triphosphate and N 6 ,O 2 -dibutyryl cyclic 3',5'-adenosine monophosphate. (1972) (14)
A new role for cardioplegic buffering: should acidosis or calcium accumulation be counteracted to salvage jeopardized hearts? (2003) (13)
Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension (2012) (13)
Oxidative insult associated with hyperoxic cardiopulmonary bypass in the infantile heart and lung. (1996) (13)
Neurotransmitters and cytokines in CNS pathology. (1994) (12)
Studies of hypoxemic/reoxygenation injury: with aortic clamping. XIII. Interaction between oxygen tension and cardioplegic composition in limiting nitric oxide production and oxidant damage. (1995) (12)
Nuclear factor-kappa B and mitogen-activated protein kinases mediate nitric oxide-enhanced transcriptional expression of interferon-beta. (2003) (12)
Continuous basal formation of endothelium-derived relaxing factor and muscle-derived relaxing factor, both of which are nitric oxide (1991) (11)
Certain S-substituted isothioureas not only inhibit NO synthase catalytic activity but also decrease translation and stability of inducible NO synthase protein. (1998) (11)
Contractile effects of 5-hydroxytryptamine in isolated intrapulmonary arteries and veins. (1981) (10)
Regulation of Polymorphonuclear Leukocyte, Macrophage, and Platelet Function (1977) (9)
Heart mtNOS, a key mediator of oxidative injury in ischemia/reperfusion. (2007) (9)
Molecular Mechanisms of Vasodilatation (1984) (9)
Up-regulation of endothelial nitric oxide synthase through beta(2)-adrenergic receptor--the role of a beta-blocker with NO-releasing action. (2001) (9)
VASCULAR SYSTEM: A HISTORICAL OVERVIEW (2002) (8)
NO More Heart Disease: How Nitric Oxide Can Prevent--Even Reverse--Heart Disease and Strokes (2005) (8)
Lysosomal enzyme secretion from human neutrophils mediated by cyclic CMP: inhibition of cyclic GMP accumulation and neutrophil function by glucocorticosteroids. (1975) (8)
Endothelium-derived relaxing factor as a mediator of bradykinin-induced perinatal pulmonary vasodilatation in fetal sheep. (1997) (8)
Adenosine 3',5'-monophosphate formation by preparations of rat liver soluble guanylate cyclase activated with nitric oxide, nitrosyl ferroheme, S-nitrosothiols, and other nitroso compounds. (1980) (8)
The effects of amrinone does not act through a cyclic nucleotide mechanism amrinone does not act through a cyclic nucleotide mechanism in platelet rich plasma (1985) (7)
Activation and Regulation of the Nitric Oxide-Cyclic GMP Signal Transduction Pathway by Oxidative Stress (1997) (7)
Alteration of Endothelium-Dependent Arterial Relaxation by Arginine Analogs and Arginine Depletion (1990) (7)
Glycoxydation promotes vascular damage Via MAPK‐ERK/JNK pathways (2012) (7)
Regulation of tissue plasminogen activator/plasminogen activator inhibitor‐1 by hydrocortisone in rat primary astrocytes (2011) (7)
Nitric Oxide in Vascular Damage and Regeneration (2010) (6)
Nitric Oxide and Cancer (2000) (6)
Local Administration of Nitric Oxide Donor Significantly Impacts Microvascular Thrombosis (2003) (6)
The L-arginine-nitric oxide-cyclic GMP pathway mediates inhibitory nonadrenergic-noncholinergic neurotransmission in the corpus cavernosum of human and rabbit (1993) (6)
Involvement of β3-Adrenergic Receptor Activation in Human Corpus Cavernosum Function (2005) (6)
Nitric Oxide, Oxidative Stress, Immune Response and Critical Care (2010) (6)
The Damaging Outcome of the POLAR Phase III Trials Was Due to Avoidable Time-Dependent Redox Interaction between Oxaliplatin and PledOx (2021) (5)
Opposing regulatory influences of cyclic guanosine monophosphate and cyclic adenosine monophosphate in the control of cardiac muscle contraction. (1975) (5)
Erratum: Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice (Proceedings of the National Academy of Sciences of the United States of America (June 8, 2004) 101, 23 (8797-8802)) (2004) (5)
Muscarinic stimulation of cardiac guanylate cyclase. (1975) (5)
Lysosomal enzyme release in vivo: an evaluation of the mechanism of cobalt polycythemia. (1974) (5)
Structural analogs of L-argmine cause endothelium-dependent and endothelium-independent, nitric oxide-mediated cyclic GMP formation and vasodilation, and cause vasoconstriction associated with decreased cyclic GMP formation (1990) (4)
Chapter 1 Nitric oxide synthase and the production of nitric oxide (2000) (4)
Regulation of lysosomal enzyme release by prostaglandins, autonomic neurohormones and cyclic nucleotides. (1975) (4)
May Mangafodipir or Other SOD Mimetics Contribute to Better Care in COVID-19 Patients? (2020) (4)
ENZYMATIC FORMATION OF CYCLIC CMP BY MAMMALIAN TISSUES (1979) (3)
Oxygen-mediated regulation of neonatal and adult rabbit aortic tension. (1992) (3)
Hypoxia increases cGMP and decreases calcium uptake in rabbit cranial arteries. (1988) (3)
Endothelium-Dependent Regulation of Resting Levels of Cyclic GMP and Cyclic AMP and Tension in Pulmonary Arteries and Veins (1988) (3)
Heme-dependent activation of cytosolic guanylate cyclase by L-arginine-derived nitric oxide represents a novel transduction mechanism for transcellular signaling (1990) (3)
Amplified nitric oxide production by pulmonary alveolar macrophages of newborn rats. (1996) (3)
Inhibition of mammalian soluble guanylate cyclase activity by adenosine 5'-tetraphosphate, guanosine 5'-tetraphosphate and other nucleotides. (1976) (3)
Chemistry and Molecular Biology of Nitric Oxide Synthesis (1999) (3)
Contributions to a quest (1987) (3)
Mechanism of action of nitric oxide: heme-dependent activation of guanylate cyclase represents a unifying signal transduction mechanism. (1992) (3)
Nitric Oxide : Biology and Pathobiology Ed. 3 (2017) (3)
Arachidonic acid and acetylcholine induced relaxation of bovine coronary artery: effect of indomethacin and methylene blue. (1986) (2)
NO news is not necessarily good (1999) (2)
Stimulation of mammalian adenylate cyclase activity with guanosine 5'-tetraphosphate and other guanine nucleotides. (1978) (2)
Comment on “Evidence that the ProPerDP method is inadequate for protein persulfidation detection due to lack of specificity” (2021) (2)
Endothelium-dependent relaxation and the acute pulmonary vascular response to alveolar hyperoxia in neonatal pigs. (1993) (2)
Lysosomal Enzyme Release: A Possible Mechanism of Action of Cobalt as an Erythropoietic Stimulant (1974) (2)
Influence of human menopausal gonadotrophin treatment on testicular blood flow and on seminal plasma nitric oxide levels in infertile males. (2006) (2)
The effects of amrinone on human platelet aggregation: evidence that amrinone does not act through a cyclic nucleotide mechanism in platelet rich plasma. (1985) (2)
Chapter 19. Non-steroidal Anti-inflammatory Agents (1969) (1)
Chapter 25. Non-steroidal Anti-inflammatory Agents (1970) (1)
Third International Conference on the Biochemistry and Molecular Biology of Nitric Oxide (1998) (1)
Oxidation ofnitric oxideinaqueous solution tonitrite butnot nitrate: Comparison withenzymatically formednitric oxide fromL-arginine (1993) (1)
New species may create new problems: norepinephrine in the heart of the avian embryo. (1967) (1)
Herbalife nutritional products and liver injury revisited. (2008) (1)
Interaction of nitric oxide (NO) and superoxide radical (O2-) in tumoricidal activity against a human ovarian cancer cell line in vitro: mechanism of action (1995) (1)
The novel role of epigenetics in primary prevention of cardiovascular diseases (2012) (1)
Inhibition of lipoxygenase enzyme in vitro by the cytochrome P-450 inhibitors metyrapone and SKF-525-A (1984) (1)
Cigarette smoke alters aortic endothelium-dependent vasorelaxation (nitric oxide) (1995) (1)
Nitric Oxide in the Regulation of Blood Flow: A Historical Overview (2000) (1)
Normoxic management of cyanotic immature hearts on CPB to reduce reoxygenation injury (1995) (1)
Long-term effects of estradiol administration on serum nitric oxide levels in postmenopausal women (1997) (0)
NGMethyl-L-arginine causes endothelium-dependent contraction and inhibition of cyclic GMP formation in artery and vein ( vascular smooth muscle / nitric oxide ) (0)
NITRICOXIDE AS A MEDIATOR OF RELAXATION OF THE CORPUS CAVERNOSUM. AUTHOR'SREPLIES (1992) (0)
Changes in gastrointestinal smooth muscle reactivity during pregnancy may be induced by nitric oxide (1995) (0)
pathophysiologyendothelial senescence: from mechanisms to (2015) (0)
RELEASE OF CARTILAGE M UCOPOLYSACCHARI DE-DEGRADING NEUTRAL P ROTEASE F ROM H UMAN L EUKOCYTES (1973) (0)
CIRCULATING WBC INDUCIBLE NITRIC OXIDE SYNTHASE (iNOS) mRNA IS EXPRESSED BY 3 HOURS AFTER LPS IN‐VIVO AND MAY PARTICIPATE IN THE INITIATION OF HYPOTENSION,: 197 (1998) (0)
Bioregulation of Lysosomal Enzyme Secr( Roles of Guanosine 3':5'-Monophosphate (2016) (0)
Physiological and pathophysiological roles of endothelium-derived nitric oxide (NO) in the heart (1992) (0)
P067. Effect of changing redox status on the activation of soluble guanylate cyclase by nitrogen oxides (2006) (0)
Iglial cell production of no: possible role in multiple sclerosis (1995) (0)
PO8-191 AUTOLOGOUS BONE MARROW CELL THERAPY AND METABOLIC INTERVENTION IN THE ISCHEMIC LIMB OF SPONTANEOUSLY HYPERTENSIVE RATS (2007) (0)
HORMONAL CONTROL OF LYSOSOMAL ENZYME RELEASE Materials and Methods Isolation of Human Neutrophils and Mixed Leukocytes (0)
PO22-710 THE NITRIC OXIDE-RELEASING BETA-BLOCKER NEBIVOLOL MAY REDUCE ATHEROSCLEROSIS IN CHOLESTEROL-FED RABBITS (2007) (0)
Reply to Klar: Key role of YY1 in neoangiogenesis (2010) (0)
IL1 Nitric oxide as a mediator of erectile function (2011) (0)
heavy-intensity, knee-extension exercise and femoral artery blood flow during 2 Kinetics of V?o (2015) (0)
An in vitro model for estimating chondromucoprotein degradation by human polymorphonuclear leukocytes utilizing 35S labelled cartilage (1973) (0)
Exacerbated Neuropathy in POLAR A and M Trials Due to Redox Interaction of PledOx-Associated Mn2+ and Oxaliplatin-Associated Pt2+ (2023) (0)
Response : Cytidylate Cyclase: Possible Artifacts in the Methodology (1979) (0)
PO13-338 BRAIN PROTECTION USING INTEGRATIVE MANAGEMENT WITH AUTOLOGOUS BONE MARROW CELLS, TRANSGENE OVEREXPRESSION OF TISSUE METALLOPROTEINASE INHIBITORS AND METABOLIC TREATMENT IN CEREBRAL ISCHEMIA (2007) (0)
CONTROLLED CARDIAC REOXYGENATION REDUCES NITRIC OXIDE (NO) PRODUCTION AND OXIDANT INJURY OP HYPOXEMIC INFANT HEARTS (1994) (0)
Third International Conference on Cyclic Nucleotides, New Orleans, Louisiana, U.S.A., July 17-22, 1977 : [proceedings] (1978) (0)
10 Involvement of beta3-adrenergic receptor activation via cyclic GMP in human corpus cavernosum function (2004) (0)
Modulation of Coronary Arterial Prostacyclin Synthetase Activity (1985) (0)
B4. Nitric oxide suppresses the expression of the tolerogenic transcription factor FOXP3 in tumor cells (2007) (0)
Ornithine Decarboxylase (ODC) is the initial enzyme in the polyamine biosynthetic pathway (2001) (0)
Prostate Cancer Prostate-Specific Antigen following Surgery or Radiation for Phase II Study of Pomegranate Juice for Men with Rising Updated (2006) (0)
Contents Vol. 63, 1999 (2000) (0)
NITRIC OXIDE (NO) PRODUCTION BY PULMONARY ALVEOLAR MACROPHAGES (AM) FROM NEONATAL, INFANT AND ADULT RATS (1994) (0)
Inhaled Nitric Oxide and COVID-19 (2020) (0)
Enhanced actions of nitric oxide in modulating gastrointestinal smooth muscle function during pregnancy (1995) (0)
HEMORRHAGIC INDUCED ALTERATIONS IN VASCULAR SMOOTH MUSCLE AND ENDOTHELIAL RESPONSES ARE NOT DUE TO NITRIC OXIDE.: 194 (1996) (0)
1426: Involvement of Beta3-Adrenergic Receptor Activation via Cyclic GMP in Human Corpus Cavernosum Function (2004) (0)
213 ADIPOSE-DERIVED STEM CELL-SEEDED SMALL INTESTINAL SUBMUCOSA IN RAT PEYRONIE'S DISEASE MODEL FOR TUNICA ALBUGINEA GRAFTING AND RECONSTRUCTION (2012) (0)
Nitric Oxide in the Development of Vascular Diseases and Regenerative Angiogenesis (2011) (0)
Nitric oxide: Biosynthesis, metabolism, and biological actions (1993) (0)
Research recommendations and conclusions from the National Institutes of Child Health and Human Development Conference on Endothelium-Derived Vasoactive Substances in Perinatal Research. (1991) (0)
Smooth Muscle Tone (2005) (0)
Experimental Autoimmune Encephalomyelitis in Nitric Oxide Synthase Inhibits Induction of Cutting Edge: Antisense Knockdown of Inducible (1998) (0)
CONJUGATED , OR ENCAPSULATED 553 is real ESSEN (2017) (0)
Eflect of Number of Leukocytes and Time of Incubalion on Nonphagocytic Release of Enzymes from Huma (2003) (0)

This paper list is powered by the following services:

Other Resources About Louis Ignarro

en.wikipedia.org

What Schools Are Affiliated With Louis Ignarro?

Louis Ignarro is affiliated with the following schools:

Image Attributions

Image Source for Louis Ignarro